NCT07070843

Brief Summary

This study was designed as a prospective, randomized controlled experimental study aiming to compare different approaches to eye care in intensive care patients receiving mechanical ventilation. In this study, patients receiving mechanical ventilation in the intensive care unit will be randomly assigned to four groups using a simple randomization method:

  1. 1.Control Group: Standard Eye Care
  2. 2.Intervention Group 1: Eye Care with Eye Care Kit
  3. 3.Intervention Group 2: Eye Care According to Eye Care Protocol
  4. 4.Intervention Group 3: Eye Care with Both Protocol and Eye Care Kit Research Hypotheses H1: Eye care provided using a care protocol is more effective in preventing the development of complications compared to standard eye care.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
156

participants targeted

Target at P75+ for not_applicable

Timeline
5mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress64%
Jul 2025Oct 2026

First Submitted

Initial submission to the registry

June 20, 2025

Completed
11 days until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

July 17, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

January 29, 2026

Status Verified

January 1, 2026

Enrollment Period

10 months

First QC Date

June 20, 2025

Last Update Submit

January 27, 2026

Conditions

Keywords

Critical care nursingEye infectionsIntensive care unitsNursing care

Outcome Measures

Primary Outcomes (3)

  • Conjunctival Edema in Critically Ill Patients

    Conjunctival Edema (Chemosis): Chemosis is the edema of the conjunctiva, which is a thin, transparent membrane covering the inner surface of the eyelids and the white part of the eyes (sclera). It refers to the swelling of this membrane that lines the ocular surface.

    Data collection was conducted for 10 consecutive days, beginning 24 hours after admission to the intensive care unit.

  • Ocular Infections in Critically Ill Patients

    Signs and Symptoms of Ocular Infection: Redness, ocular discharge, crusting along the eyelid margins, adhesion of eyelashes (eyelashes sticking together), corneal discoloration (loss of corneal transparency), periorbital edema.

    Data collection was conducted for 10 consecutive days, beginning 24 hours after admission to the intensive care unit.

  • Dry Eye in Critically Ill Patients

    Dry Eye: Dry eye is a multifactorial disease of the ocular surface, defined by tear film instability and associated with symptoms including ocular discomfort, burning sensation, irritation, dryness, visual blurring, and foreign body sensation."

    Data collection was conducted for 10 consecutive days, beginning 24 hours after admission to the intensive care unit.

Study Arms (4)

Control Group: Standard Eye Care Group

EXPERIMENTAL

There is no established protocol or guideline for eye care in the intensive care unit where the study will be conducted. Routine eye care involves the use of sterile gauze and sterile saline. During routine suctioning procedures, patients' eyes are not closed. If a patient is unable to achieve full eyelid closure, their eyes are covered with an eye patch or sterile gauze. The Schirmer test will be administered to both eyes on the first day (prior to the first eye care intervention), as well as on the fifth, seventh, and tenth days after eye care is performed. Signs and symptoms of eye infection and chemosis will be evaluated daily after the second eye care procedure. Data for this group will be collected, and the administration and documentation of eye care will be monitored.

Other: Control Group: Standard Eye Care Group

Intervention Group 1: Eye Care Using an Eye Care Kit

EXPERIMENTAL

Eye care will be performed using an eye care kit. All nursing staff in the intensive care unit will receive training regarding the contents and usage of the kit. Patients in this group will receive eye care solely using the kit, following a 4-times-daily care protocol. For patients with lagophthalmos, eyes will be covered using the eye closure pad provided in the kit. The Schirmer test will be performed on both eyes on the first day prior to the initial eye care intervention, and on the fifth, seventh, and tenth days following eye care, with results recorded. Signs of infection and chemosis will be assessed daily after the second eye care session. Data collection will be done using , and eye care administration will be tracked.

Other: Intervention Group 1: Eye Care Using an Eye Care Kit

Intervention Group 2: Eye Care According to an Eye Care Protocol

EXPERIMENTAL

All ICU nursing staff will be educated on the eye care protocol. A copy of the protocol will be posted on the doors of the rooms of patients receiving care under the protocol. Patients' ocular risk factors will be assessed daily, followed by eye care based on the protocol. Changes in ocular condition will be assessed and documented, and ICU physicians will be informed as necessary. In cases of incomplete eyelid closure, eyes will be covered upon physician notification. Patients will be assessed daily for signs of eye infection and conjunctival edema in accordance with the protocol. If signs of infection or complications occur during the day, they will be marked with a (+) symbol on the form. The Schirmer test will be applied on the first day (prior to the initial eye care session) and after eye care on days 5, 7, and 10, with results documented.

Other: Intervention Group 2: Eye Care According to an Eye Care Protocol

Intervention Group 3: Eye Care Using Both the Eye Care Protocol and the Eye Care Kit

EXPERIMENTAL

ICU nursing staff will be educated on the eye care protocol. A copy of the protocol will be posted on the doors of the rooms of patients receiving this combined care. Eye care will be performed using the Eye Care Kit developed by the researchers in accordance with the protocol. Patients will be assessed for ocular risk factors daily, and eye care will be provided according to the management guidelines of the protocol. In cases of incomplete eyelid closure, the eyes will be covered with physician knowledge. Patients will be assessed daily for signs of infection and conjunctival edema as per the protocol. Any signs of infection or complications will be marked with a (+) on the form. The Schirmer test will be performed on both eyes before the first eye care session on day 1, and following eye care on days 5, 7, and 10, with results recorded.

Other: Intervention Group 3: Eye Care Using Both the Eye Care Protocol and the Eye Care Kit

Interventions

There is no established protocol or guideline for eye care in the intensive care unit where the study will be conducted. Routine eye care involves the use of sterile gauze and sterile saline. During routine suctioning procedures, patients' eyes are not closed. If a patient is unable to achieve full eyelid closure, their eyes are covered with an eye patch or sterile gauze. The Schirmer test will be administered to both eyes on the first day (prior to the first eye care intervention), as well as on the fifth, seventh, and tenth days after eye care is performed. Signs and symptoms of eye infection and chemosis will be evaluated daily after the second eye care procedure. Data for this group will be collected, and the administration and documentation of eye care will be monitored.

Control Group: Standard Eye Care Group

* All ICU nursing staff will be educated on the eye care protocol. A copy of the protocol will be posted on the doors of the rooms of patients receiving care under the protocol. * Patients' ocular risk factors will be assessed daily, followed by eye care based on the protocol. * Changes in ocular condition will be assessed and documented, and ICU physicians will be informed as necessary. * In cases of incomplete eyelid closure, eyes will be covered upon physician notification. * Patients will be assessed daily for signs of eye infection and conjunctival edema in accordance with the protocol. If signs of infection or complications occur during the day, they will be marked with a (+) symbol on the form. * The Schirmer test will be applied on the first day (prior to the initial eye care session) and after eye care on days 5, 7, and 10, with results documented.

Intervention Group 2: Eye Care According to an Eye Care Protocol

* ICU nursing staff will be educated on the eye care protocol. A copy of the protocol will be posted on the doors of the rooms of patients receiving this combined care. * Eye care will be performed using the Eye Care Kit developed by the researchers in accordance with the protocol. * Patients will be assessed for ocular risk factors daily, and eye care will be provided according to the management guidelines of the protocol. * In cases of incomplete eyelid closure, the eyes will be covered with physician knowledge. * Patients will be assessed daily for signs of infection and conjunctival edema as per the protocol. Any signs of infection or complications will be marked with a (+) on the form. * The Schirmer test will be performed on both eyes before the first eye care session on day 1, and following eye care on days 5, 7, and 10, with results recorded.

Intervention Group 3: Eye Care Using Both the Eye Care Protocol and the Eye Care Kit

Eye care will be performed using an eye care kit. All nursing staff in the intensive care unit will receive training regarding the contents and usage of the kit. Patients in this group will receive eye care solely using the kit, following a 4-times-daily care protocol. For patients with lagophthalmos, eyes will be covered using the eye closure pad provided in the kit. The Schirmer test will be performed on both eyes on the first day prior to the initial eye care intervention, and on the fifth, seventh, and tenth days following eye care, with results recorded. Signs of infection and chemosis will be assessed daily after the second eye care session. Data collection will be done using , and eye care administration will be tracked.

Intervention Group 1: Eye Care Using an Eye Care Kit

Eligibility Criteria

Age18 Days+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Receiving mechanical ventilation
  • Glasgow Coma Scale (GCS) score \< 12
  • At least 24 hours have passed since ICU admission

You may not qualify if:

  • Diagnosed with brain death
  • Presence of facial or ocular trauma
  • Patients with head trauma
  • Patients who have undergone brain surgery
  • Patients diagnosed with an eye infection or chemosis
  • Withdrawal Criteria:
  • Patient's death during the study period
  • Extubation of the patient before completion of the care period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Sciences (Sağlık Bilimleri Üniversitesi)

Istanbul, Istanbul, 34668, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Eye Infections

Condition Hierarchy (Ancestors)

InfectionsEye Diseases

Study Officials

  • Yildiz Deniz

    University of Health Sciences (Sağlık Bilimleri Üniversitesi)

    PRINCIPAL INVESTIGATOR
  • Besey Oren

    University of Health Sciences (Sağlık Bilimleri Üniversitesi)

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Student

Study Record Dates

First Submitted

June 20, 2025

First Posted

July 17, 2025

Study Start

July 1, 2025

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

January 29, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

Individual participant data (IPD) that underlie the results reported in publications derived from this study will be made available to qualified researchers. Shared data will include de-identified datasets and related data dictionaries.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
IPD and related documents will be available starting 6 months after the primary results are published and will remain accessible for up to 5 years from that date.
Access Criteria
Access will be granted to qualified researchers for academic, non-commercial research purposes. Interested researchers must submit a methodologically sound proposal and obtain approval from the study's data access committee. All data will be shared in a de-identified format via secure transfer. The applicant must agree to a data use agreement ensuring data confidentiality and ethical use.

Locations